Current status of robotic adrenalectomy in the United States.

Autor:	Grogan RH; Section Chief of Endocrine Surgery, Baylor St. Luke's Medical Center, Houston, TX, USA.
Jazyk:	angličtina
Zdroj:	Gland surgery [Gland Surg] 2020 Jun; Vol. 9 (3), pp. 840-843.
DOI:	10.21037/gs.2020.03.39
Abstrakt:	Since its introduction more than 30 years ago, laparoscopic adrenalectomy has become the gold standard approach to adrenal surgery for the majority of adrenal pathology. It has been shown to have superior clinical benefits to open adrenalectomy for the majority of cases of adrenal surgery. Robot-assisted adrenalectomy has also been shown to be a reasonable alternative approach to adrenal gland resection. Even though robot-assisted adrenalectomy has been performed in the United States for more than 20 years, it has yet to become the gold-standard for this operation, evidenced by the fact that in the United States laparoscopic adrenalectomy remains more common than robot-assisted adrenalectomy. Market factors, clinical factors and surgeon factors all play a role in the spread and adoption of robotic surgery in general. Here we review the most up to date literature on the state of robotic adrenalectomy in the United States, and explore some of the factors that may be influencing the rate of adoption of robotic adrenalectomy in the United States. Competing Interests: Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/gs.2020.03.39). The series “Robotic Adrenalectomy” was commissioned by the editorial office without any funding or sponsorship. The author has no other conflicts of interest to declare. (2020 Gland Surgery. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu